Image

Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients

Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients

Recruiting
55-80 years
All
Phase N/A

Powered by AI

Overview

To evaluate the relationship between abnormal protein or metabolite expression levels in peripheral blood and postoperative delirium in elderly patients undergoing cardiac surgery.

Eligibility

Inclusion Criteria:

  1. patients between 55 and 80 years old,
  2. American Society of Anesthesiologists (ASA) physical status of II-III and New York Heart Association grade of II-III.
  3. The planned cardiac surgery.
  4. Hospitalization duration not less than 5 days.
  5. The anesthesia time will be no less than 2 hours.All patients had a normal ability to hear, read and cooperate with neuropsychological tests.

Exclusion Criteria:

  1. The pre-operative Montreal Cognitive Assessment (MoCA) score was less than 25,
  2. Patients with dementia, history of neurological or psychiatric disease, hospital with anxiety depression scale (HADS) over eight points,
  3. Currently use sedatives or antidepressants, Patients with substance dependence on drugs or alcohol.
  4. Patients with liver and kidney dysfunction, patients with a history of cardiac surgery.
  5. Admitted to the ICU for more than two days within the month preceding the current surgery,
  6. Unable to cooperate with researcher's investigations.

Study details
    Delirium

NCT06194474

Jining First People's Hospital

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.